127 related articles for article (PubMed ID: 12015200)
1. The novel and systemically active metabotropic glutamate 1 (mGlu1) receptor antagonist 3-MATIDA reduces post-ischemic neuronal death.
Moroni F; Attucci S; Cozzi A; Meli E; Picca R; Scheideler MA; Pellicciari R; Noe C; Sarichelou I; Pellegrini-Giampietro DE
Neuropharmacology; 2002 May; 42(6):741-51. PubMed ID: 12015200
[TBL] [Abstract][Full Text] [Related]
2. Activation of mGlu1 but not mGlu5 metabotropic glutamate receptors contributes to postischemic neuronal injury in vitro and in vivo.
Meli E; Picca R; Attucci S; Cozzi A; Peruginelli F; Moroni F; Pellegrini-Giampietro DE
Pharmacol Biochem Behav; 2002 Sep; 73(2):439-46. PubMed ID: 12117599
[TBL] [Abstract][Full Text] [Related]
3. Differential role of mGlu1 and mGlu5 receptors in rat hippocampal slice models of ischemic tolerance.
Werner CG; Scartabelli T; Pancani T; Landucci E; Moroni F; Pellegrini-Giampietro DE
Eur J Neurosci; 2007 Jun; 25(12):3597-604. PubMed ID: 17610579
[TBL] [Abstract][Full Text] [Related]
4. Group I metabotropic glutamate receptors stimulate the activity of poly(ADP-ribose) polymerase in mammalian mGlu1-transfected cells and in cortical cell cultures.
Meli E; Baronti R; Pangallo M; Picca R; Moroni F; Pellegrini-Giampietro DE
Neuropharmacology; 2005; 49 Suppl 1():80-8. PubMed ID: 16023154
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist, (+)-2-methyl-4 carboxyphenylglycine (LY367385): comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 receptors.
Bruno V; Battaglia G; Kingston A; O'Neill MJ; Catania MV; Di Grezia R; Nicoletti F
Neuropharmacology; 1999 Feb; 38(2):199-207. PubMed ID: 10218860
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and electrophysiological studies on (S)-(+)-2-(3'-carboxybicyclo(1.1.1)pentyl)-glycine (CBPG), a novel mGlu5 receptor agonist endowed with mGlu1 receptor antagonist activity.
Mannaioni G; Attucci S; Missanelli A; Pellicciari R; Corradetti R; Moroni F
Neuropharmacology; 1999 Jul; 38(7):917-26. PubMed ID: 10428410
[TBL] [Abstract][Full Text] [Related]
7. 1-Aminoindan-1,5-dicarboxylic acid and (S)-(+)-2-(3'-carboxybicyclo[1.1.1] pentyl)-glycine, two mGlu1 receptor-preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischaemia.
Pellegrini-Giampietro DE; Cozzi A; Peruginelli F; Leonardi P; Meli E; Pellicciari R; Moroni F
Eur J Neurosci; 1999 Oct; 11(10):3637-47. PubMed ID: 10564371
[TBL] [Abstract][Full Text] [Related]
8. Protection with metabotropic glutamate 1 receptor antagonists in models of ischemic neuronal death: time-course and mechanisms.
Pellegrini-Giampietro DE; Peruginelli F; Meli E; Cozzi A; Albani-Torregrossa S; Pellicciari R; Moroni F
Neuropharmacology; 1999 Oct; 38(10):1607-19. PubMed ID: 10530822
[TBL] [Abstract][Full Text] [Related]
9. Metabotropic glutamate 1 (mGlu1) receptor antagonists enhance GABAergic neurotransmission: a mechanism for the attenuation of post-ischemic injury and epileptiform activity?
Cozzi A; Meli E; Carlà V; Pellicciari R; Moroni F; Pellegrini-Giampietro DE
Neuropharmacology; 2002 Aug; 43(2):119-30. PubMed ID: 12213266
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection by group I mGlu receptors in a rat hippocampal slice model of cerebral ischemia is associated with the PI3K-Akt signaling pathway: a novel postconditioning strategy?
Scartabelli T; Gerace E; Landucci E; Moroni F; Pellegrini-Giampietro DE
Neuropharmacology; 2008 Sep; 55(4):509-16. PubMed ID: 18606174
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of the allosteric agonist of metabotropic glutamate receptor 7 AMN082 on oxygen-glucose deprivation- and kainate-induced neuronal cell death.
Domin H; Jantas D; Śmiałowska M
Neurochem Int; 2015 Sep; 88():110-23. PubMed ID: 25576184
[TBL] [Abstract][Full Text] [Related]
12. In vitro pharmacological and rat pharmacokinetic characterization of LY3020371, a potent and selective mGlu
Witkin JM; Ornstein PL; Mitch CH; Li R; Smith SC; Heinz BA; Wang XS; Xiang C; Carter JH; Anderson WH; Li X; Broad LM; Pasqui F; Fitzjohn SM; Sanger HE; Smith JL; Catlow J; Swanson S; Monn JA
Neuropharmacology; 2017 Mar; 115():100-114. PubMed ID: 26748052
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective actions of novel and potent ligands of group I and group II metabotropic glutamate receptors.
Kingston AE; O'Neill MJ; Bond A; Bruno V; Battaglia G; Nicoletti F; Harris JR; Clark BP; Monn JA; Lodge D; Schoepp DD
Ann N Y Acad Sci; 1999; 890():438-49. PubMed ID: 10668448
[TBL] [Abstract][Full Text] [Related]
14. Metabotropic glutamate autoreceptors of the mGlu(5) subtype positively modulate neuronal glutamate release in the rat forebrain in vitro.
Thomas LS; Jane DE; Harris JR; Croucher MJ
Neuropharmacology; 2000 Jul; 39(9):1554-66. PubMed ID: 10854900
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of group I metabotropic glutamate receptor responses in vivo in rats by a new generation of carboxyphenylglycine-like amino acid antagonists.
Kingston AE; Griffey K; Johnson MP; Chamberlain MJ; Kelly G; Tomlinson R; Wright RA; Johnson BG; Schoepp DD; Harris JR; Clark BP; Baker RS; Tizzano JT
Neurosci Lett; 2002 Sep; 330(2):127-30. PubMed ID: 12231428
[TBL] [Abstract][Full Text] [Related]
16. Stereoselective synthesis and preliminary evaluation of (+)- and (-)-3-methyl-5-carboxy-thien-2-yl-glycine (3-MATIDA): identification of (+)-3-MATIDA as a novel mGluR1 competitive antagonist.
Costantino G; Marinozzi M; Camaioni E; Natalini B; Sarichelou I; Micheli F; Cavanni P; Faedo S; Noe C; Moroni F; Pellicciari R
Farmaco; 2004 Feb; 59(2):93-9. PubMed ID: 14871500
[TBL] [Abstract][Full Text] [Related]
17. Excitatory amino acid receptor ligands: resolution, absolute stereochemistry, and enantiopharmacology of 2-amino-3-(4-butyl-3-hydroxyisoxazol-5-yl)propionic acid.
Johansen TN; Ebert B; Bräuner-Osborne H; Didriksen M; Christensen IT; Søby KK; Madsen U; Krogsgaard-Larsen P; Brehm L
J Med Chem; 1998 Mar; 41(6):930-9. PubMed ID: 9526567
[TBL] [Abstract][Full Text] [Related]
18. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist.
Gasparini F; Lingenhöhl K; Stoehr N; Flor PJ; Heinrich M; Vranesic I; Biollaz M; Allgeier H; Heckendorn R; Urwyler S; Varney MA; Johnson EC; Hess SD; Rao SP; Sacaan AI; Santori EM; Veliçelebi G; Kuhn R
Neuropharmacology; 1999 Oct; 38(10):1493-503. PubMed ID: 10530811
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.
Monn JA; Valli MJ; Massey SM; Hansen MM; Kress TJ; Wepsiec JP; Harkness AR; Grutsch JL; Wright RA; Johnson BG; Andis SL; Kingston A; Tomlinson R; Lewis R; Griffey KR; Tizzano JP; Schoepp DD
J Med Chem; 1999 Mar; 42(6):1027-40. PubMed ID: 10090786
[TBL] [Abstract][Full Text] [Related]
20. LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors.
Kingston AE; Ornstein PL; Wright RA; Johnson BG; Mayne NG; Burnett JP; Belagaje R; Wu S; Schoepp DD
Neuropharmacology; 1998; 37(1):1-12. PubMed ID: 9680254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
